Slingshot Biosciences Stock

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

Sign up today and learn more about Slingshot Biosciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Slingshot Biosciences Stock

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics. The company aims to bring simple, elegant, and cost-effective solutions to common problems facing research and development programs.

Funding History

July 2021$23.0M
February 2023$11.0M

Management

Co-Founder, CEO, and President

Jeff Kim

Board Member

William (Bill) Hyun

Board Member

Corey Ritter

Co-Founder

Jeremy Agresti

Board Member

Adam Wieschhaus

Co-Founder and Director of Business Development and Commercialization

Anh-Tuan Nguyen

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo